论文部分内容阅读
(2014-12-31)[2015-02-03]http://www.sfda.gov.cn/WS01/CL0051/111687.html苯溴马隆临床上主要用于原发性和继发性高尿酸血症、各种原因引起的痛风以及痛风性关节炎非急性发作期的治疗,目前主要在德国和日本、新加坡等一些亚洲国家使用。国家药品不良反应监测数据库分析显示,苯溴马隆的严重不良反应中肝损害问题比较突出。根据国内药品不良反应监测及国外监管措施情况,食品药品监管总局组织开展了苯溴马隆的风险效益评估,认为苯溴马隆在我国治疗痛风或高尿酸血症的获益仍大于
(2014-12-31) [2015-02-03] http://www.sfda.gov.cn/WS01/CL0051/111687.html Benzbromarone clinical mainly for primary and secondary high Uricaceae, gout due to various causes and treatment of non-acute episodes of gouty arthritis are currently used mainly in Asian countries such as Germany, Japan and Singapore. National adverse drug reaction monitoring database analysis showed that serious side effects of benzbromarone in liver damage problems more prominent. According to the domestic adverse drug reactions monitoring and foreign regulatory measures, the State Food and Drug Administration has conducted a risk-benefit assessment of benzbromarone that benzbromarone in our treatment of gout or hyperuricemia benefit is still greater than